| scholarly article | Q13442814 |
| P50 | author | Antonia M. Calafat | Q28656527 |
| Metrecia L Terrell | Q41589506 | ||
| P2093 | author name string | Michele Marcus | |
| Adrianne Holmes | |||
| Krista Yorita Christensen | |||
| Michael A McGeehin | |||
| Mildred Maisonet | |||
| P2860 | cites work | The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water | Q24623988 |
| Association between postnatal catch-up growth and obesity in childhood: prospective cohort study | Q24646104 | ||
| Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth | Q24647791 | ||
| Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden | Q24676545 | ||
| Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort | Q24680484 | ||
| Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth | Q24680500 | ||
| Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 | Q24680576 | ||
| Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life | Q28244591 | ||
| ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology | Q29615794 | ||
| Analyses of case-control data for additional outcomes | Q31111314 | ||
| Body mass index reference curves for the UK, 1990 | Q34796304 | ||
| Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome | Q34998270 | ||
| Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study | Q35941792 | ||
| Interference of pollutants with PPARs: endocrine disruption meets metabolism. | Q37349822 | ||
| Role of prenatal characteristics and early growth on pubertal attainment of British girls | Q41576262 | ||
| Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort | Q41576387 | ||
| Maternal exposure to perfluorinated acids and fetal growth | Q43253111 | ||
| Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation | Q44458021 | ||
| Tracking the development of adiposity from one month of age to adulthood. | Q44954404 | ||
| Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. | Q46012667 | ||
| Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha | Q46339438 | ||
| Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats | Q46343476 | ||
| Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort | Q46442964 | ||
| Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse | Q46506455 | ||
| Effects of perfluorooctanoic acid exposure during pregnancy in the mouse | Q46895745 | ||
| Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. | Q51775249 | ||
| Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. | Q52002130 | ||
| Timing of maturation and predictors of menarche in girls enrolled in a contemporary British cohort | Q57385959 | ||
| Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction | Q64131735 | ||
| P433 | issue | 10 | |
| P921 | main subject | human pregnancy | Q11995 |
| P304 | page(s) | 1432-1437 | |
| P577 | publication date | 2012-08-30 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls | |
| P478 | volume | 120 |
| Q35732620 | Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations |
| Q33584961 | Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study |
| Q37357430 | Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study |
| Q99556536 | Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco |
| Q64260723 | Associations of Fetal Growth Outcomes with Measures of the Combined Xenoestrogenic Activity of Maternal Serum Perfluorinated Alkyl Acids in Danish Pregnant Women |
| Q36350881 | Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK) |
| Q62091444 | Concentrations of endocrine disrupting chemicals in newborn blood spots and infant outcomes in the upstate KIDS study |
| Q37600475 | Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum |
| Q36707568 | Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. |
| Q52647308 | Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes. |
| Q30244853 | Do environmental pollutants increase obesity risk in humans? |
| Q29247894 | Early Life Exposure to Endocrine Disrupting Chemicals and Childhood Obesity and Neurodevelopment |
| Q47789399 | Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? |
| Q99623638 | Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects |
| Q38833921 | Early-life exposures to persistent organic pollutants in relation to overweight in preschool children. |
| Q28079540 | Effects of Environmental Exposures on Fetal and Childhood Growth Trajectories |
| Q91347645 | Environmental contaminants and child's growth |
| Q28396514 | Environmental influences on reproductive health: the importance of chemical exposures |
| Q59324594 | Evolution and Prenatal Development |
| Q60451302 | Examining Endocrine Disruptors Measured in Newborn Dried Blood Spots and Early Childhood Growth in a Prospective Cohort |
| Q36112088 | Exposure to Endocrine-Disrupting Chemicals during Pregnancy and Weight at 7 Years of Age: A Multi-pollutant Approach |
| Q36406073 | Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data |
| Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
| Q37477980 | Exposure to perfluorooctane sulfonate in utero reduces testosterone production in rat fetal Leydig cells |
| Q33963798 | First year growth in relation to prenatal exposure to endocrine disruptors - a Dutch prospective cohort study |
| Q42617846 | Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study |
| Q39153097 | Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors |
| Q102152315 | Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life |
| Q34527766 | Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism |
| Q90356625 | Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q33829016 | Maternal Exposure to Synthetic Chemicals and Obesity in the Offspring: Recent Findings |
| Q33864460 | Maternal glomerular filtration rate in pregnancy and fetal size |
| Q64125808 | Maternal serum concentrations of perfluoroalkyl substances and birth size in British boys |
| Q91961959 | Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight |
| Q102051737 | Metabolic Signatures of the Exposome-Quantifying the Impact of Exposure to Environmental Chemicals on Human Health |
| Q92949725 | Metabolomics of childhood exposure to perfluoroalkyl substances: a cross-sectional study |
| Q36023451 | Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study |
| Q36968190 | Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort |
| Q40137662 | Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study |
| Q50111987 | Perfluoroalkyl acids (PFAAs) and anthropometric measures in the first year of life: Results from the Duisburg Birth Cohort. |
| Q38265262 | Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review |
| Q50041743 | Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study |
| Q90380155 | Perfluorobutanesulfonic acid (PFBS) potentiates adipogenesis of 3T3-L1 adipocytes |
| Q58702616 | Perfluorooctanoic Acid (PFOA) Exposure in Early Life Increases Risk of Childhood Adiposity: A Meta-Analysis of Prospective Cohort Studies |
| Q36350887 | Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants |
| Q40361981 | Prenatal Exposure to Perfluoroalkyl Substances and Body Fatness in Girls |
| Q49960524 | Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study. |
| Q57144626 | Prenatal Exposure to Perfluoroalkyl Substances: Infant Birth Weight and Early Life Growth |
| Q37385404 | Prenatal Exposure to Perfluorocarboxylic Acids (PFCAs) and Fetal and Postnatal Growth in the Taiwan Maternal and Infant Cohort Study |
| Q36675487 | Prenatal Phthalate, Perfluoroalkyl Acid, and Organochlorine Exposures and Term Birth Weight in Three Birth Cohorts: Multi-Pollutant Models Based on Elastic Net Regression |
| Q38836021 | Prenatal concentrations of Perfluoroalkyl substances and early communication development in British girls |
| Q63352694 | Prenatal concentrations of perfluoroalkyl substances and bone health in British girls at age 17 |
| Q47344726 | Prenatal exposure to endocrine disrupting chemicals and birth weight-A prospective cohort study |
| Q57187566 | Prenatal exposure to organochlorine pesticides and early childhood communication development in British girls |
| Q64136246 | Prenatal exposure to perfluoroalkyl substances and adipocytokines: the HOME Study |
| Q49218786 | Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow-up: a prospective cohort study |
| Q52691577 | Prenatal exposure to polychlorinated biphenyls and fetal growth in British girls. |
| Q36396103 | Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study |
| Q36582254 | Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q28392052 | Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA |
| Q41595188 | State of the evidence 2017: an update on the connection between breast cancer and the environment |
| Q36112054 | The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study |
| Q44980589 | The Hokkaido Birth Cohort Study on Environment and Children's Health: cohort profile-updated 2017. |
| Q26851809 | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth |
| Q39869857 | Umbilical Cord Serum 25-Hydroxyvitamin D Concentrations and Relation to Birthweight, Head Circumference and Infant Length at Age 14 Days |
| Q37685542 | Urinary arsenic, pesticides, heavy metals, phthalates, polyaromatic hydrocarbons, and polyfluoroalkyl compounds are associated with sleep troubles in adults: USA NHANES, 2005-2006. |
| Q64137858 | Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood |
Search more.